503
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Update on B-cell targeted therapies for systemic lupus erythematosus

, MD, FRCP

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chi Chiu Mok. (2016) Treat-to-target in systemic lupus erythematosus: are we there yet?. Expert Review of Clinical Pharmacology 9:5, pages 675-680.
Read now

Articles from other publishers (5)

Garth E. Ringheim, Matthew Wampole & Kinsi Oberoi. (2021) Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures. Frontiers in Immunology 12.
Crossref
Philipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, Ngan Nguyen, Federica Morandi, Jared Head, Alison O’Mahony, Simone C. Zimmerli, Lisa Bruns, Andrew T. Bender, Patricia Schroeder & Roland Grenningloh. (2019) Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models. The Journal of Immunology 202:10, pages 2888-2906.
Crossref
Jolien Suurmond, Justine Calise, Susan Malkiel & Betty Diamond. (2016) DNA-reactive B cells in lupus. Current Opinion in Immunology 43, pages 1-7.
Crossref
Fulvia Ceccarelli, Carlo Perricone, Laura Massaro, Enrica Cipriano, Cristiano Alessandri, Francesca Romana Spinelli, Guido Valesini & Fabrizio Conti. (2015) Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows. Autoimmunity Reviews 14:7, pages 601-608.
Crossref
Lele Guo, Wen Liu, Tingting Lu, Wenjie Guo, Jian Gao, Qiong Luo, Xuefeng Wu, Yang Sun, Xudong Wu, Yan Shen & Qiang Xu. (2015) Decrease of Functional Activated T and B Cells and Treatment of Glomerulonephitis in Lupus-Prone Mice Using a Natural Flavonoid Astilbin. PLOS ONE 10:4, pages e0124002.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.